Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing

Danish Medical Journal

Volumn 62, Issue 2, 2015, Pages

  Løkkegaard, Thomas ^a   Pedersen, Tina Heidi ^a   Lind, Bent ^b   Siersma, Volkert ^a   Waldorff, Frans Boch ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Elective Laboratory of the Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; DECISION SUPPORT SYSTEM; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTICE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; QUALITY CONTROL; RETROSPECTIVE STUDY; TREATMENT DURATION; ADOLESCENT; ADULT; CHILD; DENMARK; DRUG MONITORING; HEALTH CARE QUALITY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; POINT OF CARE SYSTEM; PROCEDURES; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTICOAGULANTS; CHILD; DENMARK; DRUG MONITORING; FEMALE; GENERAL PRACTICE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LINEAR MODELS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; TIME FACTORS; WARFARIN; YOUNG ADULT;

EID: 84928242450     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Keeling D, Baglin T, Tait C et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematology 2011;154:311-24.
2. Connolly SJ, Pogue J, Eikelboom J et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 2008;118:2029-37.
3. Garcia DA. Patients with stable, therapeutic INR values should remain on warfarin. J Thrombosis Thrombolysis 2013;35:336-8.
4. Rådet for Anvendelse af Dyr Sygehusmedicin. Oral antikoagulationsbehandling ved non-valvulær atrieflimren. Copenhagen: Danish Regions, 2013.
5. Telemedicinsk VKA-behandling i Region Syddanmark. Region of Southern Denmark, 2013.
6. Holm T, Lassen JF, Husted SE et al. The quality of routine oral anticoagulant therapy in a large geographical area. A survey of 310,300 inhabitants. Dan Med Bull 2002;49:252-5.
7. Holm T, Lassen JF, Husted SE et al. A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy. J Int Med 2002;252:322-31.
8. THROMBO-Base - en teknologivurdering af et beslutningsstøttesystem og en klinisk database til AK-behandling. Copenhagen: DSI Institut for Sundhedsvæsen, 2005.
9. Rosendaal FR, Cannegieter SC, van der Meer FJ et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thrombo Haemostas 1993;69:236-9.
10. Ansell J, Hollowell J, Pengo V et al. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). J Thrombo Thrombolys 2007;23:83- 91.
11. Claes N, Buntinx F, Vijgen J et al. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Eur Heart J 2005;26: 2159-65.
12. Fitzmaurice DA, Hobbs FD, Murray ET et al. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial. Arch Int Med 2000;160:2343-8.
13. Mearns ES, White CM, Kohn CG et al. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thrombo J 2014;12:14.
14. Skov J, Leppin A, Bladbjerg EM et al. Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients. Thrombo Haemostas 2012;108:581-2.
15. De Caterina R, Husted S, Wallentin L et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis- Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 2012;59:1413-25.
16. Rose AJ, Hylek EM, Ozonoff A et al. Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA). Circ Cardiovasc Qual Outcom 2011;4:22-9.
17. DAK-E. www.dak-e.dk/flx/dk/andre-sundhedsprofessionelle/ ak-behandling/ (1 Oct 2014).
18. Dimberg I, Grzymala-Lubanski B, Hagerfelth A et al. Computerised assistance for warfarin dosage - effects on treatment quality. Eur J Int Med 2012; 23: 742-4.
19. Rose AJ, Petrakis BA, Callahan P et al. Organizational characteristics of high- and low-performing anticoagulation clinics in the Veterans Health Administration. Health Ser Res 2012;47:1541-60.
20. Rose AJ, Hylek EM, Ozonoff A et al. Relevance of current guidelines for organizing an anticoagulation clinic. Am J Man Care 2011;17:284-9.